About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

ATAC - Endometrial Sub-Protocol

NCT00814125·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

45–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Patients eligible for entry into the main ATAC trial (1033IL/0029)
Not received any previous tamoxifen, for whatever reason
Not undergone a hysterectomy and do not have a hysterectomy planned within the next 6 years
No previous endometrial ablation

You may not be if

Excluded from entry into the main ATAC trial (1033IL/0029). As detailed in Section 4.4 of the main ATAC trial (1033IL/0029)

The record

StatusCompleted

PhasePhase 3

Taking part285

StartedJun 1997

UpdatedMay 1, 2009

Conditions

Clareo Health | ATAC - Endometrial Sub-Protocol